CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-16 | Wood Larry L Global President TAVR & Surg | Shares withheld for taxes | −333 | $76.19 | $25K | 198,192.74 |
| 2025-02-14 | LORANGER STEVEN R Director | Option exercise | +5,739 | $45.32 | $260K | 66,111 |
| 2025-02-14 | LORANGER STEVEN R Director | Sale | −5,739 | $76.42 | $439K | 60,372 |
| 2025-02-14 | LORANGER STEVEN R Director | Option exercise · Director Stock Option (Right to Acquire) | −5,739 | 0 | ||
| 2025-02-13 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +11,250 | $45.28 | $509K | 41,811 |
| 2025-02-13 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −11,250 | $75.76 | $852K | 30,561 |
| 2025-02-13 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −11,250 | 33,750 | ||
| 2025-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +6,500 | $45.28 | $294K | 53,435.72 |
| 2025-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −100 | $76.26 | $8K | 53,335.72 |
| 2025-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −6,400 | $75.74 | $485K | 46,935.72 |
| 2025-02-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −6,500 | 19,000 | ||
| 2025-02-13 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +500 | $45.28 | $23K | 23,689.07 |
| 2025-02-13 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −500 | $76.34 | $38K | 23,189.07 |
| 2025-02-13 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −500 | 1,030 | ||
| 2025-02-13 | STONE HEISZ LESLIE Director | Option exercise | +5,739 | $45.32 | $260K | 35,774 |
| 2025-02-13 | STONE HEISZ LESLIE Director | Sale | −5,739 | $75.86 | $435K | 30,035 |
| 2025-02-13 | STONE HEISZ LESLIE Director | Option exercise · Director Stock Option (Right to Acquire) | −5,739 | 0 | ||
| 2025-01-16 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +500 | $45.28 | $23K | 23,689.07 |
| 2025-01-16 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −500 | $68.76 | $34K | 23,189.07 |
| 2025-01-16 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −500 | 1,530 |
Page 18 of 27 · 525 trades